CVS Health Co. (NYSE:CVS) Shares Sold by Transatlantique Private Wealth LLC

Transatlantique Private Wealth LLC trimmed its stake in CVS Health Co. (NYSE:CVS) by 48.6% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,308 shares of the pharmacy operator’s stock after selling 10,706 shares during the quarter. Transatlantique Private Wealth LLC’s holdings in CVS Health were worth $648,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Summit Trail Advisors LLC boosted its stake in shares of CVS Health by 33.3% during the 2nd quarter. Summit Trail Advisors LLC now owns 14,282 shares of the pharmacy operator’s stock worth $843,000 after purchasing an additional 3,564 shares during the last quarter. Sound Shore Management Inc. CT acquired a new stake in CVS Health during the second quarter worth approximately $68,854,000. Skandinaviska Enskilda Banken AB publ grew its stake in CVS Health by 2.1% in the 2nd quarter. Skandinaviska Enskilda Banken AB publ now owns 255,435 shares of the pharmacy operator’s stock worth $15,086,000 after acquiring an additional 5,300 shares during the period. AE Wealth Management LLC raised its holdings in CVS Health by 12.3% in the 2nd quarter. AE Wealth Management LLC now owns 56,116 shares of the pharmacy operator’s stock valued at $3,314,000 after acquiring an additional 6,151 shares during the last quarter. Finally, Drexel Morgan & Co. lifted its stake in shares of CVS Health by 99.6% during the 2nd quarter. Drexel Morgan & Co. now owns 200,165 shares of the pharmacy operator’s stock worth $11,822,000 after purchasing an additional 99,900 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Price Performance

Shares of CVS stock opened at $57.51 on Friday. The firm has a fifty day moving average of $58.31 and a two-hundred day moving average of $62.60. The firm has a market cap of $72.20 billion, a P/E ratio of 10.11, a P/E/G ratio of 0.79 and a beta of 0.53. CVS Health Co. has a 1-year low of $52.77 and a 1-year high of $83.25. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating the consensus estimate of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The firm had revenue of $91.23 billion during the quarter, compared to analyst estimates of $91.41 billion. During the same period in the previous year, the company earned $2.21 earnings per share. CVS Health’s quarterly revenue was up 2.6% on a year-over-year basis. As a group, research analysts anticipate that CVS Health Co. will post 6.51 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Monday, October 21st will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.63%. The ex-dividend date of this dividend is Monday, October 21st. CVS Health’s dividend payout ratio is presently 46.75%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on CVS shares. Robert W. Baird assumed coverage on CVS Health in a research report on Thursday, May 30th. They set a “neutral” rating and a $61.00 target price on the stock. Barclays reduced their target price on CVS Health from $65.00 to $63.00 and set an “equal weight” rating on the stock in a report on Thursday, August 8th. Baird R W upgraded CVS Health to a “hold” rating in a research note on Thursday, May 30th. Cantor Fitzgerald reiterated a “neutral” rating and set a $62.00 target price on shares of CVS Health in a report on Monday, September 16th. Finally, Wells Fargo & Company raised their price target on shares of CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a report on Monday, August 12th. Eleven equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $72.10.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.